Skip to main content
. 2021 Apr 15;460:53–68. doi: 10.1016/j.neuroscience.2021.02.017

Fig. 6.

Fig. 6

Labelling strength in MD and Sub following injection of CTB into ALO, PLO, or PVO. (A) Average labelling strength in MD across coronal sections −1.88, −2.12, −2.30, and −2.56 mm from bregma.) (B) Average labelling strength in Sub across coronal sections −2.12, −2.30, and −2.56 mm from bregma. (C) Labelling strength in Sub after ALO, PLO, or PVO injections at coronal sections −2.12, −2.30, or −2.56 mm from bregma. n ALO = 6, n PLO = 5, n PVO = 4 injections. c: central; l: lateral; m: medial; D: dorsal; V: ventral; ALO: lateral orbitofrontal cortex, anterior area; CTB: cholera toxin subunit B; MD: mediodorsal nucleus of the thalamus; PLO: lateral orbitofrontal cortex, posterior area; PVO: ventral orbitofrontal cortex, posterior area; Sub: submedius nucleus of the thalamus.